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Abstract: The long road from emerging biotechnologies to commercial “green” biosynthetic routes
for chemical production relies in part on efficient microbial use of sustainable and renewable waste
biomass feedstocks. One solution is to apply the consolidated bioprocessing approach, whereby
microorganisms convert lignocellulose waste into advanced fuels and other chemicals. As lignocellu-
lose is a highly complex network of polymers, enzymatic degradation or “saccharification” requires a
range of cellulolytic enzymes acting synergistically to release the abundant sugars contained within.
Complications arise from the need for extracellular localisation of cellulolytic enzymes, whether
they be free or cell-associated. This review highlights the current progress in the consolidated bio-
processing approach, whereby microbial chassis are engineered to grow on lignocellulose as sole
carbon sources whilst generating commercially useful chemicals. Future perspectives in the emerging
biofoundry approach with bacterial hosts are discussed, where solutions to existing bottlenecks could
potentially be overcome though the application of high throughput and iterative Design-Build-Test-
Learn methodologies. These rapid automated pathway building infrastructures could be adapted for
addressing the challenges of increasing cellulolytic capabilities of microorganisms to commercially
viable levels.
Keywords: lignocellulose degradation; cellulases; biofoundry; consolidated bioprocessing; synthetic
biology
1. Introduction
Many of the social and technological advances in the last century, from transportation
fuels to materials and pharmaceuticals, have been due to an increase in our understanding
and utilisation of organic chemistry [1]. Much of this chemistry relies on the use of fossil
carbon as synthons and is therefore inextricably coupled to the petrochemical industries.
These reactions often require high temperatures, high pressures and rare metal catalysts [1],
thereby generating polluting waste. Recognition of a global environmental crisis is in
part driven by our over use and reliance on petroleum-based fuels and chemistries [2].
Alternative “green” synthetic routes have been developed, utilising non-fossil fuel-derived
renewable biomass as synthons [3–13]. These emerging biotechnologies rely on the micro-
bial conversion of biological carbon biomass (e.g., sugar cane; biomass waste streams) into
advanced synthetic fuels and bio-based chemistries [14]. A report into the development
of the bio-economy through to 2030 suggests biotechnological routes have the potential
to produce 75% of pharmaceutical or 35% of total chemicals currently made via synthetic
chemistry [15].
Traditional genetic engineering routes to biocatalytic processes are increasingly being
superseded by synthetic biology technology, which employs a fermentative recombinant
microbial approach to fine chemical production [5,16–20]. In this case, individual “parts”
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of the introduced enzyme pathway(s) (e.g., enzyme homologues, promoters and ribosomal
binding sites) are optimised to increase the flow through the pathway [21–23]. This process
is often assisted by computer-aided-design programs to predict the optimal arrangement
and sequence of each component [24]. This revolutionary approach allows for the develop-
ment of de novo pathways to chemicals not found in nature, and can take advantage of
enzyme engineering technologies to generate enzymes that catalyse novel reactions [25].
Examples of (bio)compounds produced by engineered microorganisms using a synthetic
biology approach include artemisinic acid [26], β-farnesene [27], linalool [17,28,29], noscap-
ine [30], butanol [31], 6-aminocaproic acid [32] and styrene [33]. The most complex to date
was the complete synthesis of noscapine in Saccharomyces cerevisiae; an antitumor alkaloid
derived naturally from Papever somniferum (opium poppy) [30]. In this case, eighteen
heterologous enzymes were expressed in S. cerevisiae, of which only thirteen sequences
were obtained from the native poppy.
While the uptake of bio-based synthetic routes is increasing, significant advances are
needed to increase the cost-effectiveness of these processes, to enable them to compete
commercially with existing synthetic chemical or native biological routes [34]. As a result,
few biosynthetic routes have reached industrial commercialisation, largely due to low
product yields and the high cost of feedstocks. The largest scale commercial bioprod-
uct is bioethanol produced from S. cerevisiae [35], with 29,000 million gallons generated
worldwide in 2019 [36]. Most bioethanol is produced through anaerobic fermentation of
glucose derived from either corn or sugarcane [37,38]. However, both crops are in direct
competition with land use for food production. In a world where deforestation and famine
are major issues, this has led some people to declare these fuels of little benefit compared
to traditional fossil fuels [39].
A more environmentally sustainable solution is the utilisation of waste plant biomass
or lignocellulose waste. Each year, around 200 billion tonnes of lignocellulosic waste are
produced by industries such as farming and agriculture [40], and have limited commercial
value. Typically, this waste would either be combusted, composted or used as a bulking
agent in animal feed. The utilisation of this waste in synthetic biology applications could
add commercial value to the waste and provide a carbon neutral source of fuels and other
high value compounds. However, existing commercial microbial fermentations utilising
lignocellulose waste as a carbon source rely on the release of the abundant recalcitrant
sugars (e.g., glucose) via expensive pre-treatment strategies [41].
An alternative approach could be to employ a consolidated bioprocessing (CBP) strat-
egy, whereby biocatalytic enzyme production, lignocellulose degradation (saccharification)
and fermentation are accomplished within a single microorganism. This approach would
likely reduce feedstock pre-processing requirements (and associated costs), making a more
industrially viable and “green” process. To achieve this, either existing commercial strains
require engineering to incorporate an extracellular localising cellulolytic system, or sec-
ondary product biocatalytic pathways need to be integrated into naturally cellulolytic
microorganisms.
This review discusses current approaches and challenges for the utilisation of waste
lignocellulose biomass as a feedstock for building a robust microbial chassis which can
produce high value biomaterials, thereby enabling “green” solutions to biochemical produc-
tion, and be competitive with chemical synthesis. We later propose the future application
of tools developed by the rapidly expanding application of biofoundries, which have
had a significant impact on the production of biosynthetic pathways, to the challenges of
producing novel, cellulolytic biofactories.
2. Lignocellulose as a Carbon Source
2.1. Lignocellulose: A Heterogeneous Source of Polymeric Sugars
Lignocellulose is potentially an ideal target as a low-cost carbon and energy source
for microorganisms as it is the most abundant biologically derived polymer found in
nature [14]. It is composed of an intricate species-specific network of cellulose (40–50%),
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hemicellulose (20–40%) and lignin (20–35%). The hemicellulose interweaves with cellulose
polymers, while the lignin content protects the cellulose from degradation [42]. The
compact and intertwining nature of the individual polymer types in lignocellulose makes
it a multifaceted and challenging task for enzymatic degradation.
The major saccharification target is cellulose, a polysaccharide composed β-1,4 linked
D-glucose (Figure 1) [43]. This polysaccharide can pack together using a network of
hydrogen bonding (i.e., “crystalline” cellulose) to form tightly packed microfibrils, which
are difficult to be degraded by enzymes [43]. This is due to the difficulty of lignocellulose-
degrading enzymes to gain access to the majority of the glucose monomers when it is in
the crystalline state. Therefore, lignocellulose usually undergoes thermochemical or similar
pre-treatment strategies prior to enzymatic saccharification to remove the hemicellulose
and lignin, and decrease the crystallinity of the cellulose fibres. As glucose is the most
widely accepted carbon source for microorganisms [44], unlocking this recalcitrant cellulose
to release the abundant glucose molecules makes lignocellulose a potentially rich feedstock.
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Lignin is a complex heteropolymer composed of units of phenylpropane derivatives, 
such as p-coumaryl-, coniferyl- and sinapyl alcohols (Figure 2b) [42]. These compounds 
are linked via C–C and C–O bonds, and form p-phenyl- (H type), guaiacyl- (G type) and 
syringyl (S type) structural monomers. Lignin is covalently linked to both cellulose and 
hemicellulose, and provides the plant with structural support and impermeability. It also 
functions as a resistance against microbial attack and oxidative stress. Given these char-
acteristics, lignocellulose requires pre-treatment to remove lignin to release the cellulose 
prior to enzymatic saccharification. Lignin is generally not considered to be a target car-
bon source for microorganism cultivation, but instead is a source of valuable phenolic 
synthons for the production of high-value compounds [49,50].  
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Currently, most commercial and pilot scale processes utilising lignocellulose as a 
feedstock require physical and/or chemical pre-treatments to remove hemicellulose and 
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lulose then undergo enzymatic hydrolysis by commercial cocktails of cellulolytic enzymes 
to release glucose for later fermentations [51]. There are four main classes of lignocellulose 
pre-treatment strategies tested for their effectiveness in releasing amorphous cellulose 
with minimal inhibitory compounds. The first are purely physical techniques designed to 
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ultrasound and high-pressure homogenisation [41]. These energy-intensive processes suc-
cessfully reduce the crystallinity of the cellulose, but are generally not commercially viable 
options. 
A second group of pre-treatments are physio-chemical processes, such as steam ex-
plosion and hot liquid water treatment [41]. Steam explosion treatment is an effective pro-
cess, leading to the breakage of the fibres, allowing easy access of enzymes to the cellulose 
for hydrolysis to occur. It also causes delignification and solubilisation of hemicellulose. 
However, hemicellulose transformation is incomplete, and toxic compounds are released. 
Chemical treatments with acids [52], alkalis [53], oxidation agents, biological solvents [54] 
and aqueous–organic solvents have also been devised with mixed success [41]. They often 
successfully remove lignin with low inhibitor release, but suffer from high reagent costs 
and the need for corrosion resistance in scaled equipment. The final class of pre-treat-
ments is purely biological, where cellulolytic microorganisms are used to partially decom-
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brown, white and soft rot fungi, with higher yields of glucose release after later enzymatic 
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Lignin is a complex heteropolymer composed of units of phenylpropane derivatives,
such as p-coumaryl-, coniferyl- and sinapyl alcohols (Figure 2b) [42]. These compounds
are linked via C–C and C–O bonds, and form p-phenyl- (H type), guaiacyl- (G type)
and syringyl (S type) structural monomers. Lignin is covalently linked to both cellulose
and hemicellulose, and provides the plant with structural support and impermeability.
It also functions as a resistance against microbial attack and oxidative stress. Given
these characteristics, lignocellulose requires pre-treatment to remove lignin to release
the cellulose prior to enzymatic saccharification. Lignin is generally not considered to be
a target carbon source for microorganism cultivation, but instead is a source of valuable
phenolic synthons for the production of high-value compounds [49,50].
2.2. Lignocellulose Pre-Treatments
Currently, most commercial and pilot scale processes utilising lignocellulose as a feed-
stock require physical and/or chemical pre-treatments to remove hemicellulose and lignin,
reduce the crystallinity of the cellulose and minimise the release of hemicellulose-derived
inhibitory compounds (e.g., furfural). The resultant amorphous regions of the cellulose
then undergo enzymatic hydrolysis by commercial cocktails of cellulolytic enzymes to
release glucose for later fermentations [51]. There are four main classes of lignocellulose
pre-treatment strategies tested for their effectiveness in releasing amorphous cellulose with
minimal inhibitory compounds. The first are purely physical techniques designed to break
down the size of cellulose fibres and degrade lignin and hemicellulose. These techniques
include size reduction (chipping, grinding and milling), microwave irradiation, ultrasound
and high-pressure homogenisation [41]. These energy-intensive processes successfully
reduce the crystallinity of the cellulose, but are generally not commercially viable options.
A second group of pre-treatments are physio-chemical processes, such as steam explo-
sion and hot liquid water treatment [41]. Steam explosion treatment is an effective process,
leading to the breakage of the fibres, allowing easy access of enzymes to the cellulose
for hydrolysis to occur. It also causes delignification and solubilisation of hemicellulose.
However, hemicellulose transformation is incomplete, and toxic compounds are released.
Chemical treatments with acids [52], alkalis [53], oxidation agents, biological solvents [54]
and aqueous–organic solvents have also been devised with mixed success [41]. They often
successfully remove lignin with low inhibitor release, but suffer from high reagent costs
and the need for corrosion resistance in scaled equipment. The final class of pre-treatments
is purely biological, where cellulolytic microorganisms are used to partially decompose the
lignocellulose to break up its structure. Typical microorganisms used include brown, white
and soft rot fungi, with higher yields of glucose release after later enzymatic treatments due
to increased cellulose purity. The disadvantage of biological treatments is the lower reaction
rates, with extended residence times needed for efficient breakdown of lignocellulose [41].
Overall, there have been extensive studies on determining the most efficient and
cost-effective method for lignocellulose pre-treatment to maximise glucose output for
later fermentation [41,55–57]. Consideration must be paid to the type of lignocellulose
(cellulose vs. hemicellulose content), the potentially high costs involved and the formation
of toxic side products which can inhibit subsequent microbial fermentations [58]. The
environmental impact must also be considered, such as the high energy usage and harsh
chemicals needed in many pre-treatments, which impact on an otherwise “green” process.
2.3. Enzymatic Lignocellulose Degradation
More than 160,000 cellulases have been identified [59], which share a general acid/base
mechanism of catalysis [60]. These cellulose and hemicellulose degrading enzymes are
classified into different families within the CAZy (Carbohydrate-Active Enzymes) database,
based on sequence and structural features. Almost all glycosyl hydrolase (GH) cellulolytic
enzymes studied to date for commercial utilisation have originated from fungal species,
with only a few bacteria examples investigated [61]. The known crystal structures of these
enzymes show they typically contain a carbohydrate binding module, which is attached to
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the catalytic domain via a flexible linker region [42]. In addition, most fungal cellulases
have undergone N- and O-glycosylation by post-translational modification. Glycosylation
enhances catalytic activity, and increases structural and thermal stability [62]. Bacterial
cellulases do not undergo glycosylation, and the functioning of bacterial homologues is
less well understood.
Cellulose is enzymatically degraded to glucose units (C6 sugar) by glycoside hy-
drolases (cellulases) via the hydrolysis of its β-1,4 glycosidic bonds [60]. The complete
degradation of cellulose microfibrils requires the synergistic action of three types of cel-
lulases, namely an endoglucanase, exoglucanase and β-glucosidase (Figure 1) [63]. En-
doglucanases randomly cleave β-1,4-glycosidic bonds between glucose monomers within
the cellulose chain. They can be either non-processive or processive; the latter allowing
several consecutive cleavages on the same polysaccharide chain as the substrate threads
through the active site [64]. They are generally most active in the amorphous region of
cellulose [65]. Conversely, exoglucanases cleave cellobiose (glucose–glucose unit) from the
end of cellulose chains in a processive manner, and are often more active in the crystalline
regions of cellulose [66]. Processive exoglucanases are also known as cellobiohydrolases,
and are usually the major constituent of natural and commercial cellulase mixtures. Finally,
β-glucosidases cleave cellobiose to release two free glucose molecules, which can then be
used as a carbon and energy source by microorganisms [65]. Natural cellulolytic microor-
ganisms often contain several different exo- and endo-acting cellulases, to enable them to
degrade different forms/faces of cellulose [64].
In addition to classic cellulases, the glycosyl hydrolase family GH61 are known to
exhibit “cellulolytic enhancing ability” when combined with common cellulases [67]. For
example, TaGH61 from T. aurantiacus generates C1 oxidised polysaccharide oligomers
from cellulose with a non-reducing end oxidised species. This enzyme enabled an increase
in microcrystalline cellulose degradation by other cellulases in the presence of gallic
acid. This new class of enzymes are known as copper-dependent lytic polysaccharide
monooxygenases (LPMO) [64]. They cleave the glycosidic bond within crystalline regions
of the cellulose to produce aldonic acids [64]. Oxidation occurs at the C1 carbon, and
possibly also C4 and C6, dependent on the enzyme homologue. This leads to a breaking up
of the crystalline regions of cellulose, which greatly enhances the degradation of cellulose
by allowing access to traditional cellulases [42].
Due to the complex nature of hemicellulose, sugar release requires the cooperative
action of multiple types of enzymes. For xylan degradation, one of the two predomi-
nant enzymes required are endo-1,4- β-xylanases, which hydrolyse β-1,4-xylan to yield
xylo-oligosaccharides. The second major enzymes are exo-1,4- β-xylosidases, which hy-
drolyse xylobiose and xylo-oligosaccharides to produce xylose (C5 sugar). Mannan (β-1,4-
linked mannose) and glucomannan are major hemicellulose constituents of softwood [42].
Degradation of these C6-sugar polymers requires the action of endo- β-1,4-mannanases,
which hydrolyse oligosaccharides with three to four monomers. This is followed by exo-
β-1,4-mannosidase, which hydrolyses terminal non-reducing β-mannose residues. For
glucomannan cleavage, β-glucosidases cleave the bond between mannose and glucose
units in the polymer [42].
Additional accessory enzymes are found in natural systems to assist in the efficient
hydrolysis of hemicellulose [42]. These enzymes are acetylxylan esterase, feruloyl es-
terase, p-coumaroyl esterase, α-L-arabinofuranosidase, xylan α-1,2-glucuronosidase and
α-glucuronidase. However, strategies for the utilisation of lignocellulose as a carbon source
usually involve the removal of its hemicellulose content. One would envisage that the
inclusion of all eight recombinant hemicellulose-degrading enzymes as well as the three
cellulose-degrading enzymes within the target host may not be the most efficient strategy
for optimising carbon utilisation.
Commercial cellulase cocktails, produced by companies such as Novozyme, are typi-
cally made up of cellulases from T. reesei [68], supplemented with additional enzymes [69]
such as α-xylosidase [70] or GH5 [71]. The cost of using commercial enzyme cocktails to
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release free sugars from lignocellulose has been shown to represent up to 48% of the final
cost of second-generation bioethanol in some demonstration scale plants [72]. Reducing
this cost is therefore essential in the development of future cost-competitive and renewable
bio-based processes.
Lignin removal is one of the primary targets of thermochemical lignocellulose pre-
processing as it is highly insoluble and can form covalent crosslinks with hemicellulose
side chains, conferring additional strength to plant cell walls [73]. The composition of
lignin is plant species specific, and is not a readily fermentable carbon source for microor-
ganisms. There are natural enzymes that can degrade lignin, namely laccase, peroxidases,
oxidases, aryl-alcohol dehydrogenase, cellobiose dehydrogenase, catechol oxidases and
tyrosinases [42]. The exact combination of enzymes and mechanism of degradation varies
by microorganism type [74].
2.4. Cellulase Localisation
Degradation of the highly insoluble lignocellulose by microorganisms requires that
all cellulolytic enzymes must be expressed extracellularly. In naturally cellulolytic mi-
croorganisms, the extracellular saccharification machinery exists as either free (secreted)
enzymes [75], or associated with the outer membrane in multi-enzyme cellulosomal com-
plexes [76] (Figure 3). The targeting of enzymes into either cellulosomes or as free extracel-
lular enzymes is achieved by the presence of an N-terminal signalling peptide sequence.
Aerobic bacteria and fungi tend to secrete multidomain cellulases, such as Tricoderma
reesei [75]. These enzymes diffuse to and bind lignocellulose, the latter via their carbo-
hydrate binding modules (CBMs). The associated catalytic domain then hydrolyses the
substrates, releasing oligosaccharides for later hydrolysis into free sugars [77]. The cellulase
CBM domains increase the rate of hydrolysis of lignocellulose by effectively increasing
the enzyme concentration around the substrate compared to enzymes containing only a
catalytic domain.
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Cellulolytic anaerobes, such as Clostridium thermocellum, employ cell-associated multi-
enzyme cellulosomes composed of all the key hydrolases needed for lignocellulose degra-
dation (Figure 3; [78]). These complexes are formed around proteins called scaffoldins,
consisting of multiple cohesin domains and a dockerin domain. The anchoring scaffoldin
contains a single, C-ter inal, S-layer-like domain which binds peptidoglycans in the mi-
crobial cell wall, anchoring the cellulosome t the cell. The hydrolases co tain both an
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active catalytic domain and a second, non-catalytic dockerin domain. These dockerins
bind the cohesion domains and effectively target the enzyme within the cellulosome. The
CBMs are contained within the primary scaffoldin, and play a role in binding the cell to the
cellulosic substrate.
Variability exists in the exact arrangement between the different protein constituents
within cellulosomes; however, the primary roles of the components remain unchanged.
Cellulosomal systems generally have a lower lignocellulose hydrolysis rate than free en-
zyme systems, as they are limited by the upper limit of enzyme surface loading onto the
microorganism’s outer membrane [76]. In addition, enzymes displayed on cell surfaces can-
not penetrate as deep into lignocellulose as do free enzymes. In spite of this, cellulosomes
enable an increase in the localised concentration of free sugars available to the cell [79].
Additionally, cellulases often display synergism with one another, and localisation within
a cellulosome may enhance this effect [80].
A difficulty encountered with some target bacterial microbial chassis is the poor ef-
ficiency of extracellular secretion of recombinant proteins through the outer membrane,
whether it be for cell-surface display or as free enzymes. This is especially problematic
with Gram-negative bacteria, such as non-pathogenic strains of E. coli. These organisms
contain an outer membrane lipopolysaccharide bilayer that acts as an effective permeability
barrier. Enzymes are secreted via the general secretory (sec) or twin-arginine translocation
(tat) pathways, and typically end up in the periplasmic space separating the two mem-
branes [81]. Extracellular protein secretion is sometimes achieved by inefficient passive
transport from the periplasmic space via outer membrane proteins [82]. Whilst secretory
pathways are present in Gram-negative bacteria [83], they are often poorly understood and
successful extracellular secretion is technically challenging to achieve in many cases. The
challenges involved in exporting the required enzymes are one of the biggest challenges
faced for the engineering of microorganisms for CBP. A variety of factors can affect the rate
of extracellular secretion within E. coli. The most frequent problems encountered are incom-
plete secretion into the periplasmic space, insufficient capacity of the export machinery, and
proteolytic degradation of the recombinant proteins [84]. Additional factors influencing
secretion efficiency include protein size, leader peptide amino acid composition (sequence)
and protein production rates outstripping the maximal secretion rate [84].
Gram-positive bacteria, in contrast, can often secrete large amounts of recombinant
proteins into the surrounding medium, which makes them attractive microbial chassis
for growth on lignocellulose waste. Gram-positive bacteria and fungi have a single cell
membrane through which enzymes can be transported via either the sec [85] or tat path-
ways [86]. Not all classes of proteins are well secreted, but the efficiency generally outstrips
the relatively poor levels seen with Gram-negative bacteria. Efficient secretion can also
face bottlenecks of proteolytic cleavage, secretion stress with the associated metabolic bur-
den. Examples of Gram-positive bacteria with proven ability for efficient protein secretion
include the genera Bacillus, Corynebacterium, Streptomyces and Lactobacillus.
Yeast is a promising microbial host for secondary metabolite production from cells
grown on pre-treated lignocellulose. It has the added advantage of containing the cellular
machinery required for post-translational glycosylation of enzymes, enabling highly effi-
cient fungal cellulases to be expressed and secreted in an active form. For example, one
study described Saccharomyces cerevisiae strains which were engineered to secrete both a
cellulase and a xylanase for efficient degradation of partly delignified corn stover [87]. The
synergistic action of both enzymes increased ethanol titres by up to 3.4-fold compared to
wild type S. cerevisiae. A second study engineered the Clostridium thermocellum scaffoldin
gene CipA and anchoring protein gene OlpB into the industrial yeast Kluyveromyces marxi-
anus [88]. This organism expressed a cellulosome containing a mixture of dockerin-fused
fungal cellulases, including exoglucanase, β-glucosidase, endoglucanase and accessory
cellulase “booster” genes. This enabled growth on phosphoric acid-swollen cellulose,
which yielded ethanol titres of 8.61 g/L [88].
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3. Consolidated Bioprocessing
Consolidated bioprocessing (CBP) is a biomanufacturing approach that combines the
saccharification of lignocellulose waste with fermentation to produce the desired com-
pounds within the same microbial chassis [89]. By combining these steps into a single
microbial process, there is the potential to reduce the costs associated with the saccha-
rification of pre-treated lignocellulose by eliminating the need to pre-release sugars for
fermentation using expensive commercial enzyme cocktails. A successful CBP strategy
requires the microorganism to secrete a range of native or recombinant extracellular cellu-
lolytic enzymes in addition to the required pathway enzymes for making the industrially
useful secondary product.
Microbial host selection is critical when designing CBP routes to chemical and ad-
vanced synthetic fuel production. Naturally cellulolytic microorganisms are obvious
targets, as they contain all the machinery for completely digesting lignocellulose with
minimal pre-processing. However, naturally cellulolytic microorganisms may not be the
most industrially robust chassis for chemical production, and may require engineering
to introduce the pathways to make the desired compound, or improve the natural titres.
Alternatively, non-cellulolytic microorganisms which currently produce high yields of the
target compounds could be engineered to introduce a secretable cellulolytic system.
3.1. Naturally Cellulolytic Microorganisms
Naturally cellulolytic microorganisms are superbly adapted for lignocellulose degra-
dation and subsequent growth compared to de novo engineered bacteria. The major
challenge often associated with these organisms is the need to develop rapid and efficient
synthetic biology tools to enable the incorporation of pathways necessary to produce high
yields of target compounds [89]. This may include non-native pathway incorporation
and/or upregulation of cellular precursors and natural (bio)chemical production.
The main research in this area is looking at improving biofuel titres with the microor-
ganisms Trichoderma reesei, Clostridium cellulolyticum and Clostridium thermocellum grown on
lignocellulose. In one study, T. reesei CICC 40360 underwent nitrosoguanidine treatment
followed by genome shuffling mutagenesis to increase ethanol production. This improved
ethanol titres five-fold under aerobic conditions, in addition to enhancing ethanol resis-
tance [90]. The thermophilic anaerobe C. thermocellum ATCC 31924 was also investigated
for its ethanol production titres when grown on crystalline cellulose. This cellulosome-
producing strain under optimised cultivation conditions generated 0.3 g ethanol per gram
of cellulose digested, with >95% cellulose conversion [91]. A further 20% increase in
ethanol titres was achieved by shifting carbon flux away from lactate production by the
inclusion of acetate in the medium [91].
A modified isobutanol pathway was engineered in C. cellulolyticum based on the
L-valine biosynthetic pathway [92]. This route is based on diverting glucose-derived 2-keto
acid intermediates through to isobutanol using recombinant enzymes from Bacillus subtilis,
E. coli and Lactococcus lactis. Isobutanol titres of 0.66 g/L were obtained when grown on
cellulose, compared to 15–20 g/L from free glucose-based carbon sources [92]. Therefore,
increases in the cellulose utilisation rate will likely be needed before this process becomes
commercially viable. The thermophilic variant C. thermocellum also underwent engineering
for isobutanol production [93]. Unfortunately, this strain suffered from enzyme toxicity
and other challenges during pathway engineering. Eventually, a stable genomic integrated
isobutanol-producing strain was generated, showing isobutanol titres of 5.4 g/L when
grown on cellulose at 50 ◦C (41% of the theoretical yield) [93]. This study highlighted some
of the problems encountered when using non-model organisms as microbial chassis with
fewer available molecular biology tools.
3.2. Non-Cellulolytic Chemical Producers
The alternative strategy for CBP is to engineer existing microorganisms producing
commercially relevant compounds, both native and engineered systems, with a functional
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extracellular cellulolytic system. This opens up a wider range of possible microbial chassis,
and allows us to take advantage of the extensive molecular engineering toolboxes available
for model organisms. The incorporation of an efficient cellulolytic system into a new
microbial chassis requires additional considerations over biocatalytic pathway engineering,
as each enzyme must be either secreted extracellularly or displayed on the outer membrane.
Yarrowia lipolytica is a non-conventional yeast with significant biotechnological poten-
tial due to its native ability to produce bio-surfactants, γ-decalactone, citric acid, intracel-
lular lipids and lipase [94]. It has undergone multiple engineering studies to increase its
hydrolytic secretome to include growth on complex polysaccharides such as starch, cellu-
lose, xylan and inulin. Genome analysis of Y. lipolytica revealed the presence of multiple
intracellular and extracellular β-glucosidase genes and putative cellobiose transporters,
which explained why cellobiose could be assimilated intracellularly, but growth on cellu-
lose was not possible [95]. Growth on pre-treated corn stover was achieved (50%) after
engineering in the T. reesei cellulase genes EGII and CBHII [94]. A dormant pathway for
xylose utilisation was found in the Y. lipolytica genome, but not xylan degradation. Multiple
studies engineered xylanase genes into Y. lipolytica, including the cell-surface expression of
the XYN gene from Thermobacillus xylanilyticus [96]. Interestingly, the sole expression of
XynII from Trichoderma harzianum into Y. lipolytica enabled growth on birchwood xylan as
the sole carbon source [94].
The transition from first generation (sugar-starch feedstocks) to second generation
(lignocellulose biomass) bioethanol production necessitated the incorporation of secretable
saccharolytic machinery into S. cerevisiae. In one study, three cellobiohydrolases (cbh1 from
Aspergillus aculeatus and cbh1/cbh2 from Trichoderma reesei) were integrated into the genome
of S. cerevisiae under constitutive promoters, in combination with the endoglucanase eg2
(T. reesei) and β-glucosidase bgl1 from A. aculeatus. Cultures were cultivated on acid- and
alkali-pre-treated corncob-containing media, and the highest ethanol titres obtained within
7 days were 18.6 g/L [18].
Cell-surface display of cellulolytic enzymes has been demonstrated in S. cerevisiae
using the glycosylphosphatidylinositol anchoring system [97]. This was achieved by
incorporating a novel signal peptide sequence from the S. cerevisiae SED1 gene onto A.
saculeatus β-glucosidase (BGL1) and T. reesei endoglucanase II (EGII). Both secreted and
cell-associated BGL1 and EGII were detected, showing higher levels (up to 1.9-fold activity)
than using more conventional signal tags from enzymes glucoamylase (Rhizopus oryzae)
and α-mating pheromone (S. cerevisiae). Ethanol titres of these constructs were up to 8.9 g/L
when cultivated on cellobiose for 8 h [97].
An alternative to cell-surface display in S. cerevisiae is the production of trifunctional
minicellulosomes [98]. The minicellulosomes were constructed using a miniscaffoldin
containing a cellulose-binding domain and three cohesin modules, which were tethered
to the cell surface through the yeast α-agglutinin adhesion receptor. Up to three types
of cellulases were included, namely an endoglucanase, a cellobiohydrolase, and a β-
glucosidase, each containing a C-terminal dockerin. Successful minicellulosome formation
was dependent on the expression of the miniscaffoldin. These trifunctional complexes
showed enhanced enzyme–enzyme and enzyme proximity synergy, and allowed the yeast
to degrade and ferment phosphoric acid-swollen cellulose to ethanol (~1.8 g/L) [98].
Minicellulosomes have also been generated in bacterial systems, such as in the butanol-
producing bacterium Clostridium acetobutylicum [99]. The cellulolytic genes Cel9G, Cel48F,
and Xyn10A from C. cellulolyticum were integrated into the C. acetobutylicum genome with
a miniscaffoldin derived from C. cellulolyticum CipC. Cellulosome anchoring was achieved
using the native sortase system. The engineered strain demonstrated improved ability to
grow on xylan as a sole carbon source with increased butanol titres, although no growth
on cellulose polymers was observed [99].
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3.3. Model Organism: E. coli
One of the most extensively utilised microbial chassis for bioengineering development
is the bacterium E. coli. This is due to the development of an extensive genetic toolbox
for manipulating its genome and transcriptome [100], and a detailed understanding of its
endogenous metabolic pathways and regulation is available [101]. Steady-state metabolic
flux models, such as EcoCyc, can predict the effects of gene knockouts and varying nutrient
conditions [102], which are a useful tool for optimising strains for industrial applications.
E. coli also possesses physiological properties highly desirable in an industrial host, such as
fast growth kinetics [103], high levels of intracellular recombinant protein production [104],
growth under both aerobic and anaerobic conditions [105], and use of a wide range of
carbon sources including both C5 and C6 sugars [106]. The commercialisation of model
organism E. coli as a microbial chassis is demonstrated in the production of insulin [107]
and 1,3-propanediol [108].
Initial “proof-of-principle” pathway engineering and testing is commonly performed
using E. coli prior to transitioning into more industrially relevant hosts. Examples of
biotechnological routes to chemical production developed in E. coli are summarised in
Table 1. The wide range of secondary products generated by engineered E. coli include
synthetic fuels (primary and advanced), bioplastic monomers, flavours and fragrances,
platform chemicals and pharmaceutical drug intermediates [23].
Table 1. Examples of compounds produced using engineered biosynthetic pathways in E. coli.
Product Use Design Yield Ref.
1,3-Propanediol PTT production 1
Glycerol-3-phosphate dehydrogenase
(DAR1 and GPP2) from S. cerevisiae.
Glycerol dehydratase (dhaB1, dhaB2



















from B. subtilis. Ketoisovalerate






Multiple de novo metabolic routes
based on amino acid utilisation, fatty
acid biosynthesis, Clostridial butanol
production and single step from
butyric acid via fatty acid
photodecarboxylase.
30–180 mg/g/d 2 [112,113]
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Table 1. Cont.
Product Use Design Yield Ref.
(+)-Dihydrocarvide Bioplastics
Mentha spicata route to carvone with
an ene-reductase and cyclohexanone
monooxygenase variant.
6.6 mg/L [114]
Linalool Hygiene products;chemical intermediate
“Plug-and-play” monoterpenoid
production platform with linalool
synthase.
363 mg/L 3 [28,29]
Fatty acid esters Biodiesel
Thioesterase (tesA) and wax-ester
synthase. Pyruvate decarboxylase and









Limonene synthase from Mentha
spicata.
430 mg/L [116,117]
Naringenin Pharmaceuticalindustry Flavanone pathway from L-tyrosine. 199 mg/L [118]
Isopropene Synthetic rubber
Heterologous mevalonate (MVA)
pathway. Isoprene synthase from
Populus alba and P. kudzu.
60 g/L [119,120]
Taxiden-5α-ol Taxol (anti-cancer drug)
Heterologous MEP pathway. Taxidene





Knockdown of metabolic pyruvate






Pseudomonas putida and (R)-reticuline
biosynthesis.
2.1 mg/L [121,122]
1 Polytrimethylene terephthalate; 2 30–180 mg propane per g cells per day; 3 Linalool titres are mg/L organic overlay, equivalent to
73 mg/L culture.
Previous attempts to endow E. coli with cellulolytic capabilities have focused on target-
ing specific secretory mechanisms, or in some cases the exploitation of chance discoveries
(Table 2). These have included producing secreted soluble enzymes [123], cell-surface dis-
play [124] and the upregulation of naturally secreted “cryptic” cellulases in E. coli [125]. In
each case, the major challenge was to overcome the barrier of cellulase secretion beyond the
periplasmic space. This involves screening a variety of (typically) Gram-positive bacterial
N-terminal signalling tags that have been proven to enable recombinant protein secretion
in Gram-negative bacteria.
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Table 2. Engineered E. coli to facilitate growth on lignocellulose carbon sources.





















PsgA Ethanol 0.3 g/L [124]
Corn straw Endogenous cellulase Native EthanolHydrogen
0.36 g/L
3.3 mL/g [125]
The role of fusion partners in natural protein secretion in the laboratory strain E.
coli BL21(DE3) was established by examining its extracellular proteome [127]. The most
efficient fusion partner was OsmY, with titres of 250–700 mg/L of the target proteins
alkaline phosphatase (E. coli), α-amylase (B. subtilis) and human leptin under high cell
density cultivation. A later study used the OsmY-fusion protein approach to secrete β-
glucosidase (Cellvibrio japonicus), endoxylanase (Clostridium stercorarium) and xylobiosidase
(C. japonicus) from E. coli [123]. A co-culture of cellulolytic and hemicellulolytic strains
successfully grew on ionic liquid pre-treated switchgrass (Table 2). These strains were
subsequently engineered to produce fuel substitutes or precursors suitable for petrol,
diesel and jet engines. For example, cultures grown in media containing 3.9% ionic liquid
pre-treated switchgrass yielded 1.7 ± 0.6 mg/L pinene. Improvements in both biofuel
synthesis titres and lignocellulose digestion efficiencies could lead to the development of
an economical route to advanced synthetic fuels [123].
The catalytic domain of cellulase Cel-CD from Bacillus sp. Z-16 was demonstrated to
be efficiently secreted from E. coli to high levels (514 mg/L) in the absence of any known
N-terminal signalling tag (Table 2) [127,128]. However, the N-terminal twenty amino acid
sequence was found to be useful as a signalling tag to support the extracellular localisation
of recombinant proteins in E. coli. For example, cellulose-hydrolysing strains of E. coli
were engineered by fusing either Cel-CD or its N-terminal sequence to the β-glucosidase
gene from T. fusca [126]. Further engineering was performed to incorporate a poly-3-
hydroxybutyrate (PHB) synthesis pathway. This strain yielded 2.6–8.2 wt% PHB from
cultures grown on amorphous cellulose and cellobiose, respectively. Two endoxylanases
were also efficiently secreted into the culture medium when expressed with the N-terminal
tag or a Cel-CD fusion [126].
Cell-surface display of cellulases on the E. coli LY01 outer membrane has been achieved
by utilising the cell surface anchor PsgA from B. subtilis (Table 2) [129]. The C. cellulolyticum
endoglucanase (Cel5A), exoglucanase (Cel9E) and β-glucosidase were surface displayed,
allowing the strain to directly ferment dilute acid pre-treated corn stover to ethanol at
0.3 g/L. Higher titres were achieved from growth on phosphoric acid-swollen cellulose
(3.6 g/L) [124].
A strain of E. coli has been isolated from bovine rumen that was capable of fermenting
corn straw directly to both ethanol and hydrogen gas (Table 2) [125]. This strain was found
to excrete cellulases with quantifiable exoglucanase, endoglucanase and β-glucosidase
activities. Secondary product titres of 0.36 g/L ethanol and 4.71 mL/g hydrogen were
achieved from growth on corn straw, with a cellulose/hemicellulose degradation ratio of
14.3%/11.4% [125]. Therefore, native E. coli strains exist with natural cellulolytic capabili-
ties, which could potentially be exploited for secondary product generation with further
engineering to increase growth rates on lignocellulose carbon sources.
These studies demonstrate the possibility of endowing cellulolytic properties on E. coli
with secondary product titres, albeit at a reduced growth rate. In order for CBP to become
a commercial reality, both increases in target compound titres and more efficient utilisation
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of lignocellulose waste need to be significantly improved. These latter gains could be made
through the use of more efficient cellulases, improved extracellular secretion, higher levels
of enzyme synergy, secretion and/or display.
4. Looking to the Future: The Biofoundry Approach
The power of the synthetic biology revolution is the ability to bypass traditional chem-
ical syntheses and transition towards “natural” or biological production of commercially
useful compounds. In the past few years, there has been an emergence of the biofoundry
concept, which combines the strengths of the latest synthetic biological techniques with
automation and high-throughput methodologies [130] to rapidly increase the rate at which
biosynthetic pathways can be developed [131]. This emerging field of engineering biology
focuses on the rapid design, build and testing of recombinant, industrially relevant mi-
crobial chassis, with the aim of generating new microbial strains for the sustainable and
renewable production of chemicals, fuels and pharmaceuticals.
Like any assembly line, final product selection is dependent on the set of “parts”
utilised to build the biosynthetic pathway. These can include the choice of enzyme(s)
homologue/variant, transcriptional/translational control, vector backbone [132] and DNA
assembly techniques [132]. Therefore, optimal “parts” selection is critical for building
efficient biofoundries, with more complex multi-step pathways requiring considerable
optimisation screening to identify the best combination of parts for efficient production.
To minimise the optimisation process, biofoundries typically employ integrated infras-
tructures that implement iterative Design-Build-Test-Learn (DBTL) cycles. This relies on
automated pathway design and synthesis coupled to high throughput robotic screening.
This then informs further design steps to improve process efficiency [133]. Automated de-
sign steps make use of retrosynthetic pathway design tools such as RETROPATH 2.0 [134],
Selenzyme [135], PathPred [136], SimPheny [20] and SelProm [137]. For example, PathPred
is a web-based server that designs bespoke biocatalytic pathways, and predicts which
enzymes are suitable for each catalytic step [136]. This can be followed by Selenzyme, a
free online tool that provides bespoke enzyme sequence selection for each biosynthetic
step [135]. It uses existing databases to rank homologues of known biosynthetic abilities,
based on conserved amino acid sequence regions, predicted active site, predicted soluble
expression and transmembrane regions and the phylogenetic distance between the source
organism and the target chassis [135]. The optimisation of promoter type and strengths is
also critical for efficient pathway design. SelProm assists this design by acting as a parts
repository for predictable plasmid expression strengths, using machine learning to select
the best promoter systems to eliminate bottlenecks through biosynthetic pathways.
De novo robotic workflows and robotic technology platforms are key to biofoundry
development as they can rapidly generate libraries of potential pathways and generate
comparative performance data to enable the identification of the most suitable parts for
target compound production. Machine-learning techniques are an integral part of the
“Learn” step, as information from initial datasets can help make more informed decisions
in future rounds of pathway design and screening dataset size [138].
The biofoundry approach has been demonstrated using a “pressure test” at the MIT-
Broad foundry, where the challenge was to produce novel pathways to 10 compounds in
just 90 days [139]. They successfully generated microbial chassis or cell-free systems for
producing six out of the 10 targets (or a closely related molecule). Compounds produced
included 1-hexadecanol, and the antifungal and antibacterial agents pyrrolnitrin and
pacidamycin D, respectively. Novel routes were established towards the enediyne warhead
underlying powerful antimicrobials, and a precursor to the chemotherapy agent vincristine
was produced. In the case of tetrahydrofuran and barbamide production, in vivo pathway
expression led to cytotoxicity, effectively halting further developments [139].
A similar rapid prototyping of microbial cell factories challenge by SYNBIOCHEM was
performed to benchmark the capabilities of a biomanufacturing pipeline. They successfully
produced 17 potential material monomers and key intermediates out of 25 identified
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compounds within 85 days [140]. This was performed by combining 160 genetic parts into
115 unique biosynthetic pathways. Compound classes targeted included vinylbenzenes,
allylbenzenes, mandelate lactides and isobutyl compounds. The scale-up potential of
these pathways was tested by optimising the enantioselective pathways to mandelic
acid and hydroxymandelic acid. This generated gram-scale production titres using fed-
batch fermentation. These studies show the power of these emerging biofoundries to
quickly identify and implement novel pathways, albeit at “proof of principle” titres. These
activities are beginning to be coordinated through the establishment of a Global Biofoundry
Alliance [131].
Beyond proof of principle research, the biofoundry approach is a valuable tool when
considering scaled processes. Biofoundaries could be implemented for pathway redesign
and/or microbial chassis optimisation to increase chemical titres to be commercially com-
petitive with existing natural and synthetic routes. In the case of CBP technologies, this
approach could also be exploited to increase the currently slow rate of glucose release
from cellulose, which impacts on the growth rates of the microorganisms. Key “parts”
to be optimised could include maximising the synergism between (hemi)cellulolytic ho-
mologues, improving cellular excretion by de novo design of secretion tags and varying
the relative transcriptional/translational rates necessary to generate the most efficient
cellulolytic pathways. This is of particular importance when utilising (Gram-negative)
bacterial chassis, where active cellulase secretion is severely limited.
Successful implementation of the biofoundry approach for CBP requires efficient and
sensitive high throughput screening techniques to ensure a sufficient library size can be
sampled to maximise the chance of finding improved variants. Examples include the
scaling of the International Union of Pure and Applied Chemistry (IUPAC) standardised
methods for the detection of reducing sugars to a microtitre plate scale [141]. Other
methods have been developed which allow the quantification of activity from whole cell
preparations [142]. Coupled-assays based on the hydrolysis of fluorescent tags from 4-
nitrophenyl β-D-glucopyranoside [143] and 4-nitrophenyl β-D-cellobioside [144] could
also be scaled down to work in high throughput assays. Ultrahigh throughput screening
techniques have been developed for cellulases. In vitro flow cytometry was used to screen
exoglucanase variants generated through directed evolution using fluorescence from the
hydrolysis of fluorescein-di-β-D-cellobioside [145]. Screens based on both fluorophore
release [146] and coupled-assays [147] have been developed for use in microfluidics from
whole cell samples. Bioprospecting techniques have also been used on the ultrahigh
throughput scale [148]. The tools necessary to engineer novel cellulolytic pathways using
biofoundries already exist, and they may hold the key to future successes in CBP.
5. Conclusions
The often unacknowledged or underplayed bottleneck to the commercialisation of a
synthetic biology generated microbial biomanufacturing process is the need to replace pure
glucose-based carbon sources with cost-effective alternative feedstocks. Lignocellulose
appears to be an ideal low-cost abundant waste feedstock, provided the extensive network
of polymeric fibres can be degraded to release the abundant sugars contained within.
However, the enzymatic degradation of lignocellulose is a complex process requiring
thermochemical and/or mechanical pre-processing followed by the synergistic action of a
variety of saccharolytic and lignin-degrading enzymes. The incorporation of an efficient
cellulolytic system within microbial systems can be hampered by bottlenecks such as cost-
effective lignocellulose pre-processing, lack of expression of functional glycosylated fungal
cellulases in bacteria and the often-poor secretion of all the required (hemi)cellulases.
The light on the horizon is the advent of the biofoundry approach, whereby tradi-
tional synthetic biology pathway design is replaced by iterative Design-Build-Test-Learn
cycles. Between automated pathway design and synthesis, high throughput screening
and machine learning, the process from concept to functionally efficient cellulolytic and
high titre chemical producing industrial chassis might be realised in a relatively short time
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(months rather than years). The future outlook in the CBP field will therefore depend on
the continued development of efficient automated and tunable engineering platforms, to
accelerate both fundamental and applied biotechnological research to realise commercially
successful biomanufacturing platforms.
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